Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.
Saved in:
| Title: | Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring. |
|---|---|
| Authors: | Liao Y; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Li X; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Liu M; Proteomics and Metabolomics Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Fernandes VC; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Duckett D; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Haura EB; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Monastyrskyi A; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Rix U; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Department of Molecular Biosciences, University of South Florida, Tampa, Florida. |
| Source: | Cancer research communications [Cancer Res Commun] 2026 Jun 01; Vol. 6 (6), pp. 1376-1387. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
